Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers (Q84189818)
Jump to navigation
Jump to search
scientific article published on 24 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers |
scientific article published on 24 May 2011 |
Statements
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers (English)
Himanshu Naik
Majid Vakilynejad
Jingtao Wu
Prabhakar Viswanathan
Nobuhito Dote
Tomoaki Higuchi
Eckhard Leifke